Skip to content

Clinical trials

Observational Amyloid Neuropathies, Familial trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloid Neuropathies, Familial Phase: Observational Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20204
20212
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Essen5
Alnylam Pharmaceuticals2
CENTOGENE GmbH Rostock2
University of Leipzig2
AstraZeneca1
Charite University, Berlin, Germany1
Heinrich-Heine University, Duesseldorf1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloid Neuropathies, Familial15
Amyloidosis6
Polyneuropathies4
Amyloid Neuropathies3
Amyloidosis, Familial3
Aortic Valve Stenosis3
Cardiomyopathies3
Heart Failure2
Alzheimer Disease1
Cardiomyopathy, Dilated1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.